Simcere Pharmaceutical Group - Product Pipeline Review - 2015

Published: Mar, 2015 | Pages: 49 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Simcere Pharmaceutical Group - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Simcere Pharmaceutical Group - Product Pipeline Review - 2015', provides an overview of the Simcere Pharmaceutical Group's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Simcere Pharmaceutical Group's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Simcere Pharmaceutical Group including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Simcere Pharmaceutical Group's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Simcere Pharmaceutical Group's pipeline products

Reasons To Buy

- Evaluate Simcere Pharmaceutical Group's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Simcere Pharmaceutical Group in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Simcere Pharmaceutical Group's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Simcere Pharmaceutical Group and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Simcere Pharmaceutical Group
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Simcere Pharmaceutical Group and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Simcere Pharmaceutical Group Snapshot 6
Simcere Pharmaceutical Group Overview 6
Key Information 6
Key Facts 6
Simcere Pharmaceutical Group - Research and Development Overview 7
Key Therapeutic Areas 7
Simcere Pharmaceutical Group - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Simcere Pharmaceutical Group - Pipeline Products Glance 15
Simcere Pharmaceutical Group - Late Stage Pipeline Products 15
Phase III Products/Combination Treatment Modalities 15
Simcere Pharmaceutical Group - Clinical Stage Pipeline Products 16
Phase II Products/Combination Treatment Modalities 16
Phase I Products/Combination Treatment Modalities 17
Simcere Pharmaceutical Group - Early Stage Pipeline Products 18
IND/CTA Filed Products/Combination Treatment Modalities 18
Preclinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
Simcere Pharmaceutical Group - Drug Profiles 21
bendamustine hydrochloride 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
fluorouracil 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
SIM-071201 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
(irbesartan + amlodipine besylate) 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
APX-003 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
metatinib tromethamine 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
sevacizumab 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
BMS-817378 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
OSI-930 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
SIM-010603 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
BMS-795311 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
SCR-1693 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
SIM-0710 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
SIM-89 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule for Cancer 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Simcere Pharmaceutical Group - Pipeline Analysis 36
Simcere Pharmaceutical Group - Pipeline Products by Target 36
Simcere Pharmaceutical Group - Pipeline Products by Route of Administration 38
Simcere Pharmaceutical Group - Pipeline Products by Molecule Type 39
Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action 40
Simcere Pharmaceutical Group - Recent Pipeline Updates 42
Simcere Pharmaceutical Group - Dormant Projects 45
Simcere Pharmaceutical Group - Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49

List of Tables
Simcere Pharmaceutical Group, Key Information 6
Simcere Pharmaceutical Group, Key Facts 6
Simcere Pharmaceutical Group - Pipeline by Indication, 2015 9
Simcere Pharmaceutical Group - Pipeline by Stage of Development, 2015 10
Simcere Pharmaceutical Group - Monotherapy Products in Pipeline, 2015 11
Simcere Pharmaceutical Group - Combination Treatment Modalities in Pipeline, 2015 12
Simcere Pharmaceutical Group - Partnered Products in Pipeline, 2015 13
Simcere Pharmaceutical Group - Partnered Products/ Combination Treatment Modalities, 2015 14
Simcere Pharmaceutical Group - Phase III, 2015 15
Simcere Pharmaceutical Group - Phase II, 2015 16
Simcere Pharmaceutical Group - Phase I, 2015 17
Simcere Pharmaceutical Group - IND/CTA Filed, 2015 18
Simcere Pharmaceutical Group - Preclinical, 2015 19
Simcere Pharmaceutical Group - Discovery, 2015 20
Simcere Pharmaceutical Group - Pipeline by Target, 2015 37
Simcere Pharmaceutical Group - Pipeline by Route of Administration, 2015 38
Simcere Pharmaceutical Group - Pipeline by Molecule Type, 2015 39
Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action, 2015 41
Simcere Pharmaceutical Group - Recent Pipeline Updates, 2015 42
Simcere Pharmaceutical Group - Dormant Developmental Projects,2015 45
Simcere Pharmaceutical Group, Subsidiaries 46